What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus?

Immunological Reviews

Volumn 159, Issue , 1997, Pages 5-16

  Klenerman, Paul ^a   Zinkernagel, Rolf M ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; EVOLUTION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; LYMPHOCYTE DEPLETION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIREMIA; VIROGENESIS; VIRUS REPLICATION;

EID: 0030667614     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1997.tb01003.x     Document Type: Review

References (99)

1. Armstrong C, Lillie R. Experimental lymphocytic choriomeningitis of monkeys and mice produced by a virus encountered in the studies of the 1933 St Louis encephalitis epidemic. Public Health Rep 1934;49:1019-1027.
2. Traub E. A filtrable virus recovered from white mice. Science 1935;81:298-299.
3. Peters C, Jahrling P, Liu C, Kenyon R, McKee K, Oro JB. Experimental Studies of Arenaviral Haemorrhagic fevers. Curr Top Microbiol Immunol 1987;134:5-68.
4. Buchmeier MJ, Welsh RM, Dutko FJ, Oldstone MBA. The virology and immunology of lymphocytic choriomeningitis virus infection. Adv Immunol 1980;30:275-331.
5. Klenerman P, et al. Cytotoxic T cell lysis and HIV turnover. Proc Natl Acad Sci USA 1996;93: 15323-15328.
6. Salvato M, Shimomaye E. The completed sequence of LCMV reveals a unique RNA structure and a gene for a zinc finger protein. Virology 1989;173:1-10.
7. Lehmann-Grube F. Lymphocytic Choriomeningitis Virus. Virology Monographs 1971;10:1-173.
8. Ahmed R, Oldstone M. Organ specific selection of viral variants during chronic infection. J Exp Med 1988;167:1719-1724.
9. Matloubian M, Somasundaram T, Kolhekar S, Selvakumar R, Ahmed R. Genetic basis of viral persistence: single amino acid change in viral glycoprotein affects ability of LCMV to persist in adult mice. J Exp Med 1990;172:1043-1048.
10. Matloubian M, Kolhekar S, Somasundaram T, Ahmed R. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of LCMV. J Virol 1993;67:7340-7349.
11. Borrow P, Tishon A, Oldstone M. Infection of lymphocytes by a virus that aborts CTL acivity and establishes persistent infection. J Exp Med 1991;174:203-212.
12. Banerjee S, Buchmeier M, Rawls W. Requirement of a cell nucleus for the replication of an arenavirus. Intervirology 1975;6:190-196.
13. Dalgleish A, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984;312:763-767.
14. Scarlatti G, et al. Transmission of HIV-1 from mother to child correlates with viral phenotype. Virology 1993;197:624-629.
15. Spira AI, et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996;183:215-225.
16. Embretson J, et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993;362:359-362.
17. Pantaleo G, et al. Lymphoid organs function as major reservoirs for HIV Proc Natl Acad Sci USA 1991;88:9838-9842.
18. Livingstone WJ, et al. Frequent infection of peripheral blood CD8+ T-lymphocytes with HIV-1. Lancet 1996;348:649-654.
19. Lehmann-Grube F. A carrier state of LCMV in L cell cultures. Nature 1967;213:770-773.
20. Benedetto A, Garbuglia AR, Di CA, Lo PE, Alfani E, Delfini C. Virus-free survival and down-regulation of CD4 in C8166 cells infected with human immunodeficiency virus type 1 at low density. J Gen Virol 1993;74:2595-2601.
21. Feinberg M, Mclean A. AIDS: Decline and fall of immune surveillance? Curr Biol 1997;7:136-140.
22. Wei X, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-122.
23. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-126.
24. Zinkernagel RM, Althage A. Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled. J Exp Med 1977;145:644-651.
25. Yang O, et al. Efficient lysis of HIV-1-infected cells by cytotoxic T lymphocytes. J Virol 1996;70:5799-5806.
26. Pircher H, Moskphidis A, Rohrer U, Burki K, Hengartner H, Zinkernagel RM. Viral escape by selection of cytotoxic T cell-resistant variants in vivo. Nature 1990;346:629-633.
27. Aebischer T, Moskophidis D, Rohrer UH, Zinkernagel RM, Hengartner H. In vitro selection of lymphocytic chorio-meningitis virus escape mutants by cytotoxic T lymphocytes. Proc Natl Acad Sci USA 1991;88: 11047-11051.
28. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995;267:483-489.
29. Bakhanashvili M, Hizi A. The fidelity of the reverse transcriptases of human immunodeficiency viruses and murine leukemia virus, exhibited by the mispair extension frequencies, is sequence dependent and enzyme related. FEBS Lett 1993;319:201-205.
30. Cocchi F, DeVico AL, Garzino DA, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995;270:1811-1815.
31. Dragic T, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-673.
32. Oberlin E, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line adapted HIV-1. Nature 1996;382:833-835.
33. Zinkernagel RM, Doherty PC. Restriction of an in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within asyngeneic or semiallogeneic system. Nature 1974;248:701-702.
34. Zinkernagel RM, Doherty PC. H-2 compatibility requirement for T-cell mediated lysis of target cells infected with lymphocytic choriomeningitis virus. J Exp Med 1975;141:1427-1436.
35. Lehmann-Grube F, Assmann U, Loliger C, Moskophidis D, Lohler J. Mechanism of recovery from acute virus infection 1. Role of T lymphocytes in the clearance of LCMV from the spleens of mice. J Immunol 1985;134:608-615.
36. Zinkernagel RM, Leist T, Hengartner H, Althage A. Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D. J Exp Med 1985;162:2125-2141.
37. Zinkernagel RM, Pfau CJ, Hengartner H, Althage A. Susceptibility to murine lymphocytic choriomeningitis maps to class I MHC genes - a model for MHC/disease associations. Nature 1985;316:814-817.
38. Baenziger J, Hengartner H, Zinkernagel RM, Cole GA. Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus. Eur J Immunol 1986;16:387-393.
39. Kagi D, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994;369:31-37.
40. Kagi D, et al. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol 1995;25:3256-3262.
41. Kagi D, Ledermann B, Burki K, Zinkernagel RM, Hengartner H. Lymphocyte-mediated cytotoxicity in vitro and in vivo: mechanisms and significance. Immunol Rev 1995;146:95-115.
42. Moskophidis D, Lechner F, Hengartner H, Zinkernagel RM. MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice. J Immunol 1994;152:4976-4983.
43. Pircher H, et al. Characterization of virus-specific CTL clones from allogeneic bone marrow chimeras. Eur J Immunol 1987;17:159-166.
44. Gotch FM, Nixon DF, Alp N, McMichael AJ, Borysiewicz LK. High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. Int Immunol 1990;2:707-710.
45. Oehen S, Waldner H, Kundig TM, Hengartner H, Zinkernagel RM. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J Exp Med 1992;176:1273-1281.
46. Koup RA, Ho DD. Shutting down HIV. Nature 1994;370:416.
47. Safrit JT, Koup RA. The immunology of primary HIV infection: which immune responses control HIV replication? Curr Opin Immunol 1995;7:456-461.
48. Phillips A. Reduction in HIV concentration during acute infection: independence from a specific immune response. Science 1996;271:497-499.
49. Pantaleo G, et al. Major expansion of CD8+ T cells with a predominant Vb usage during the primary immune response to HIV. Nature 1994;370:463-467.
50. Callan MFC, et al. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med 1996;2:906-911.
51. Moss PAH, Moots RJ, Rosenberg WMC, Rowland-Jones SJ, McMichael AJ, Bell JI. Extensive conservation of alpha and beta chains of the human T cell antigen receptor recognizing HLA-A2 and influenza matrix peptide. Proc Natl Acad Sci USA 1991;88:8987-8991.
52. Panataleo G, et al. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viraemia. Proc Natl Acad Sci USA 1997;94:254-259.
53. Matloubian M, Concepcion RJ, Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 1994;68:8056-8063.
54. Koup RA, et al. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. J Exp Med 1991;174:1593-1600.
55. Rinaldo CJ, Beltz LA, Huang XL, Gupta P, Fan Z, Torpey D. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men. AIDS Res Hum Retroviruses 1995;11: 481-489.
56. Rinaldo C, et al. High levels of anti-HIV-1 memory CTL activity and low viral load are associated with lack of disease in HIV-1-infected long-term non-progressors. J Virol 1995;69:5838-5842.
57. Carmichael A, Jin X, Sissons P, Borysiewicz L. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 1993;177:249-256.
58. Altman J, et al. Direct visualization and phenotypic analysis of virus-specific T lymphocytes in HIV-infected individuals. Science 1996;274:94-96.
59. Chun T, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997;387:183-186.
60. Moskophidis D, Laine E, Zinkernagel RM. Peripheral clonal deletion of antiviral memory CD8+ T cells. Eur J Immunol 1993;23:3306-3311.
61. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993;362:758-761.
62. Battegay M, Moskophidis D, Rahemtulla A, Hengartner H, Mak TW, Zinkernagel RM. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J Virol 1994;68:4700-4704.
63. + T cells and interferons in persistent and acute infections of mice with LCMV: implications for adoptive immunotherapy of virus carriers. Proc Natl Acad Sci USA 1997;94:6874-6879.
64. Moss PAH, et al. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc Natl Acad Sci USA 1995;92:5773-5777.
65. Kalams SA, et al. Longitudinal analysis of TCR gene usage by HIV-1 envelope-specific CTL clones reveals a limited TCR repertoire. J Exp Med 1994;179:1261-1271.
66. Effros RB, et al. Shortened telomeres in the expanded CD28- CD8+ subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996;10:F17-22.
67. Moskophidis D, Zinkernagel RM. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus. J Virol 1995;69:2187-2193.
68. Nowak MA, et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 1995;375:606-611.
69. Jameson SC, Carbone FR, Bevan MJ. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J Exp Med 1993;177:1541-1550.
70. Jameson SC, Bevan MJ. T cell receptor antagonists and partial agonists. Immunity 1995;2:1-11.
71. Goulder P, et al. Late escape from an immunodominant CTL response associated with progression to AIDS. Nat Med 1997;3:212-217.
72. Phillips RE, et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991;354:453-459.
73. Zinkernagel RM, Hengartner H. HIV. Games that viruses play. Nature 1991;354:433-434.
74. Borrow P, et al. Antiviral pressure exerted by HIV-1 specific CTL during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 1997;3:205-211.
75. Price D, et al. Positive selection of HIV-1 CTL escape mutants during primary infection. Proc Natl Acad Sci USA 1997;94:1890-1895.
76. Klenerman P, et al. Naturally ocurring HIV-1 gag variants antagonise cytotoxic T-cell activity. Nature 1994;369:403-406.
77. Klenerman P, Meier UC, Phillips RE, McMichael AJ. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus. Eur J Immunol 1995;25:1927-1931.
78. McAdam SN, et al. Immunogenic HIV variants that bind to HLA-B8 but fail to stimulate CTL responses. J Immunol 1995;155:2729-2736.
79. Bertoletti A, et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994;369:407-410.
80. Kundig T, et al. Fibroblasts as efficient antigen presenting cells in lymphoid organs. Science 1995;268:1343-1347.
81. Thomsen A, Johansen J. Marker O, Christensen J. Exhaustion of CTL memory and recrudescence of viraemia in LCMV infected MHC Class II deficient and B cell deficient mice. J Immunol 1996;157:3075-3080.
82. Delassus S, Cheynier R, Wain-Hobson S. Nonhomogenous distribution of HIV-1 proviruses in the spleen. J Virol 1992;66:5642-5645.
83. Pantaleo G, et al. Studies in subjects with long-term nonprogressive HIV infection. N Engl J Med 1994;332:209-216.
84. Harrer E, et al. HIV-1-specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons. AIDS Res Hum Retroviruses 1994;10: 208-222.
85. Kyburz D, Speiser DE, Aebischer T, Hengartner H, Zinkernagel RM. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo. J Immunol 1993;150:5051-5058.
86. Leist TP, Ruedi E, Zinkernagel RM. Virus-triggered immune suppression in mice caused by virus-specific cytotoxic T cells. J Exp Med 1988;167:1749-1754.
87. Planz O, Seiler P, Hengartner H, Zinkernagel R. Specific CTL eliminate cells producing neutralizing antibodies. Nature 1996;382:726-730.
88. Ruedi E, Hengartner H, Zinkernagel R. Immunosuppression in mice by LCMV infection: time dependence during primary and absence of effects on secondary antibody response. Cell Immunol 1990;130:501-512.
89. Zinkernagel RM, Haenseler E, Leist T, Cerny A, Hengartner H, Althage A. T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay? J Exp Med 1986;164:1075-1092.
90. Zinkernagel RM, Hengartner H. Virally induced immunosuppression. Curr Opin Immunol 1992;4:408-412.
91. Zinkernagel R, Pircher H, Ohashi P, Hengartner H. T cells causing immunological disease. Springer Semin Immunopathol 1992;14: 105-113.
92. Zinkernagel RM, Hengartner H. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol Today 1994;15:262-268.
93. Zinkernagel R. Are HIV-specific CTL responses salutary or pathogenic? Curr Opin Immunol 1995;7:462-470.
94. Zinkernagel R. Immunosuppression by a noncytolytic virus via T cell mediated immunopathology. In: Andrieu J-M, Lu W, eds. Cell activation and Apoptosis in HIV infection. New York: Plenum Press; 1995.p.165-171.
95. Althage A, et al. Immunosuppression by LCMV infection: competent effector T and B cells but impaired antigen presentation. Eur J Immunol 1992;22:1803-1812.
96. Borrow P, Evans C, Oldstone M. Virus induced immunosuppression: immune system mediated destruction of virus infected dendritic cells results in generalised immunosuppression. J Virol 1995;69:1059-1070.
97. Moskophidis D, Pircher H, Ciernik I, Odermatt B, Hengartner H, Zinkernagel RM. Suppression of virus-specific antibody production by CD8+ class I-restricted antiviral cytotoxic T cells in vivo. J Virol 1992;66:3661-3668.
98. Battegay M, et al. Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells. J Immunol 1993;151:5408-5415.
99. Zinkernagel RM. Immunology taught by viruses. Science 1996;271:173-178.